The Safety and Efficacy Study of ISU302 in Patient With Type I Gaucher Disease
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare and evaluate the efficacy and safety of ISU302, an
investigational product, and Cerezyme®, comparator, for Type 1 Gaucher Disease patients